NHLBI is conducting a study in the transfusion Medicine/Hemostasis Clinical Trials Network (TMH CTN). STAR is a four year randomized trial for Rituximab as early treatment for Thrombotic Thrombocytopenic Purpura (TTP). The Department of Health and Human Services will serve as the Drug Distribution Center (DCC).

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
NIH Inter-Agency Agreements (Y01)
Project #
Y1HB9036-1-0-1
Application #
7980756
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2009
Total Cost
$45,450
Indirect Cost
Name
National Heart, Lung, and Blood Institute
Department
Type
DUNS #
City
State
Country
Zip Code